Solstice Advanced Materials, Inc. (SOLS) Down 5.0% — Should I Close Out and Redeploy?
Solstice Advanced Materials, Inc. (SOLS) is giving back ground on Thursday, last trading at $61.71 on the NASDAQ, a $3.28 decline from the prior close of $64.99. The stock opened at $64.00 and slid as low as $60.38 in early trading, erasing the previous session's gain and then some. SOLS now trades roughly 32.0% below its 52-week high of $90.80, reached on May 13, 2026. The stock has lost nearly a third of its value in about five months, so the activist-fueled bounce earlier this week was arriving from a depressed starting point.
Volume stands at approximately 755,687 shares with the session still open, against a 90-day average of roughly 3.02 million. Turnover is running at about a quarter of a typical full day so far, so the decline is unfolding on relatively thin participation.
Why Solstice Advanced Materials, Inc. Price is Moving Lower
The clearest explanation for today's drop is a reversal of the optimism that followed Starboard Value's arrival. On October 20, Starboard disclosed a stake in Solstice and pressed the company to concentrate on its refrigerants and nuclear businesses while cutting about $100 million in costs, according to Reuters. Shares responded the next day with a 3.06% gain to $64.99. Thursday's slide more than erases that advance, which suggests traders are fading the activist premium rather than reacting to any change in the underlying business. An activist campaign raises the possibility of change but does not deliver it, and Starboard's roadmap now has to be negotiated with management before any of the proposed savings reach the income statement.
The broader backdrop is not helping, though it does not account for the full scale of the move. The Materials Select Sector SPDR (XLB) was down just 0.42% in afternoon trading, far milder than SOLS's decline of more than 5%. Peer performance is split. AngloGold Ashanti plc (AU) is off 6.30% and Vale S.A. (VALE) has dropped 3.39%, but chemical names like Air Products and Chemicals, Inc. (APD) are up 1.48%. The pressure is concentrated in specialty chemicals. Element Solutions (ESI) fell about 8.7% intraday even after reporting adjusted EPS of $0.50 against a $0.48 estimate and revenue of $995.3 million versus roughly $964 million expected. Investors there focused on guidance calling for Q4 EBITDA of $175 million to $176 million, down from $191 million in the third quarter, along with concerns about valuation. That reaction signals a market quick to punish specialty-chemical names on any hint of decelerating earnings, and SOLS is caught in the same current.
Valuation sharpens that sensitivity. With trailing EPS of $1.32 and a forward P/E of 49.41, Solstice is priced for a meaningful earnings ramp, and that leaves little cushion when sentiment turns. The next test arrives on November 4 when Solstice reports quarterly results before the market opens. Investors will be looking for evidence that the business can support its multiple independent of any activist-driven restructuring.
What is the Solstice Advanced Materials, Inc. Rating - Should I Sell?
Weiss Ratings assigns SOLS a C- rating. Current recommendation is Hold. The C- sits at the low end of the Hold range. It reflects a company with a sound balance sheet and real top-line momentum, offset by modest profitability, a volatile stock, and almost no income return for shareholders. It is not a sell signal, but it calls for caution rather than conviction.
The strongest point in the profile is the Good rating on the Solvency Index. For a recently independent company now facing activist pressure to restructure, a balance sheet that can absorb cost-cutting programs and continued investment in its refrigerant and nuclear franchises gives management flexibility. Solvency is the one dimension where Solstice stands clearly ahead of the rest of its scorecard, and it explains much of why the overall rating holds at C- rather than slipping into Sell territory.
Where the picture becomes more nuanced is in the operating dimensions. The Fair rating on the Growth Index looks conservative next to revenue growth of 11.13%, a respectable pace for a chemicals producer. That growth has not translated into proportionate earnings power, however. A 5.12% profit margin and an 11.22% ROE help explain the Fair rating on the Efficiency Index. Those returns are adequate but thin for a portfolio built around proprietary low-global-warming refrigerants, which should carry premium pricing. That margin gap is also exactly what Starboard's $100 million cost target is aimed at. The Fair rating on the Total Return Index reflects a stock that has fallen about 32% from its May peak. The Weak Volatility Index shows up in the past three sessions alone, with an activist-driven pop followed immediately by a reversal of more than 5%. The Very Weak Dividend Index rounds out the picture, since a 0.35% yield offers investors little compensation for sitting through those swings.
Within the Materials sector, Solstice Advanced Materials sits alongside Shin-Etsu Chemical Co., Ltd. (SHECF, C-) and Air Products and Chemicals, Inc. (APD, C-). It trails Martin Marietta Materials, Inc. (MLM, C) and Vale S.A. (VALE, C), and sits a full notch behind AngloGold Ashanti plc (AU, C+), which carries a stronger risk/reward profile in Weiss's framework.
About Solstice Advanced Materials, Inc.
Solstice Advanced Materials, Inc. (SOLS) is a Materials company formed from the separation of Honeywell's advanced materials business, and it now operates as an independent specialty chemicals and materials producer. Its best-known franchise is its line of hydrofluoroolefin refrigerants and blowing agents sold under the Solstice brand, including Solstice yf for automotive air conditioning and Solstice ze and N40 for commercial refrigeration and chillers. These low-global-warming-potential products are positioned to benefit as regulators in the United States and Europe phase down older hydrofluorocarbon refrigerants, giving Solstice a structural tailwind tied to environmental policy rather than economic cycles alone.
Beyond refrigerants, the company serves a range of specialized end markets. Its nuclear business converts uranium into uranium hexafluoride for the fuel cycle at its Metropolis, Illinois facility, and it is the only uranium conversion operation in the United States. That asset has drawn attention as interest in domestic nuclear supply chains grows, and it is one of the two businesses Starboard has urged the company to prioritize. Solstice also produces Spectra ultra-high-molecular-weight polyethylene fiber used in ballistic protection and industrial applications, Aclar films for pharmaceutical blister packaging, and electronic materials used in semiconductor manufacturing, along with research and performance chemicals for laboratory and industrial customers.
The company's competitive position rests on proprietary chemistry, an extensive patent estate in next-generation refrigerants, and long-standing customer relationships inherited from Honeywell across the automotive, HVAC, defense, healthcare, and electronics markets. Regulatory qualification requirements in refrigerants, nuclear fuel, and pharmaceutical packaging create meaningful barriers to entry. The breadth of the portfolio, however, is also why activist investors see room to simplify the business and sharpen its focus.
Investor Outlook
Solstice Advanced Materials, Inc. (SOLS) carries a Weiss Rating of C- (Hold). With the stock 32% below its high, priced at nearly 50 times forward earnings, and swinging on activist headlines, a cautious stance is warranted. The November 4 earnings report is the immediate checkpoint, and investors should watch for margin improvement, management's response to Starboard's call for about $100 million in cost cuts, and any signal that the refrigerant and nuclear businesses are getting greater strategic emphasis. See full rankings of all C- rated Materials stocks inside the Weiss Stock Screener.
--